BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18780302)

  • 1. Association studies of 22 candidate SNPs with late-onset Alzheimer's disease.
    Figgins JA; Minster RL; Demirci FY; Dekosky ST; Kamboh MI
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jun; 150B(4):520-6. PubMed ID: 18780302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication study of genome-wide associated SNPs with late-onset Alzheimer's disease.
    Burns LC; Minster RL; Demirci FY; Barmada MM; Ganguli M; Lopez OL; DeKosky ST; Kamboh MI
    Am J Med Genet B Neuropsychiatr Genet; 2011 Jun; 156B(4):507-12. PubMed ID: 21480501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between UBQLN1 and Alzheimer disease.
    Slifer MA; Martin ER; Bronson PG; Browning-Large C; Doraiswamy PM; Welsh-Bohmer KA; Gilbert JR; Haines JL; Pericak-Vance MA
    Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):208-13. PubMed ID: 16526030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease.
    Morgan AR; Turic D; Jehu L; Hamilton G; Hollingworth P; Moskvina V; Jones L; Lovestone S; Brayne C; Rubinsztein DC; Lawlor B; Gill M; O'Donovan MC; Owen MJ; Williams J
    Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):762-70. PubMed ID: 17373700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.
    Grupe A; Abraham R; Li Y; Rowland C; Hollingworth P; Morgan A; Jehu L; Segurado R; Stone D; Schadt E; Karnoub M; Nowotny P; Tacey K; Catanese J; Sninsky J; Brayne C; Rubinsztein D; Gill M; Lawlor B; Lovestone S; Holmans P; O'Donovan M; Morris JC; Thal L; Goate A; Owen MJ; Williams J
    Hum Mol Genet; 2007 Apr; 16(8):865-73. PubMed ID: 17317784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
    Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    González RD; Gomes I; Gomes C; Rocha R; Durães L; Sousa P; Figueruelo M; Rodríguez M; Pita C; Hornero R; Gómez C; Lopes AM; Pinto N; Martins S
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia - mediated immunity partly contributes to the genetic association between Alzheimer's disease and hippocampal volume.
    Lancaster TM; Hill MJ; Sims R; Williams J
    Brain Behav Immun; 2019 Jul; 79():267-273. PubMed ID: 30776473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
    Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
    J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin genetic variants modify the risk for Alzheimer's disease among Finnish patients.
    Vepsäläinen S; Helisalmi S; Koivisto AM; Tapaninen T; Hiltunen M; Soininen H
    J Neurol; 2007 Nov; 254(11):1504-8. PubMed ID: 17987251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitively healthy centenarians are genetically protected against Alzheimer's disease.
    Tesi N; van der Lee S; Hulsman M; van Schoor NM; Huisman M; Pijnenburg Y; van der Flier WM; Reinders M; Holstege H
    Alzheimers Dement; 2024 Jun; 20(6):3864-3875. PubMed ID: 38634500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients.
    Gaj P; Paziewska A; Bik W; Dąbrowska M; Baranowska-Bik A; Styczynska M; Chodakowska-Żebrowska M; Pfeffer-Baczuk A; Barcikowska M; Baranowska B; Ostrowski J
    J Alzheimers Dis; 2012; 32(1):157-68. PubMed ID: 22785395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GAB2 is not associated with late-onset Alzheimer's disease in Japanese.
    Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Kuwano R
    Eur J Hum Genet; 2009 May; 17(5):682-6. PubMed ID: 18854865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association analysis of dynamin-binding protein (DNMBP) on chromosome 10q with late onset Alzheimer's disease in a large caucasian UK sample.
    Morgan AR; Hollingworth P; Abraham R; Lovestone S; Brayne C; Rubinsztein DC; Lynch A; Lawlor B; Gill M; O'Donovan MC; Owen MJ; Williams J
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jan; 150B(1):61-4. PubMed ID: 18452187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90.
    Heath L; Earls JC; Magis AT; Kornilov SA; Lovejoy JC; Funk CC; Rappaport N; Logsdon BA; Mangravite LM; Kunkle BW; Martin ER; Naj AC; Ertekin-Taner N; Golde TE; Hood L; Price ND;
    Sci Rep; 2022 Apr; 12(1):6117. PubMed ID: 35413975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
    Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of sex and SORL1 variants in italian patients with Alzheimer disease.
    Cellini E; Tedde A; Bagnoli S; Pradella S; Piacentini S; Sorbi S; Nacmias B
    Arch Neurol; 2009 Oct; 66(10):1260-6. PubMed ID: 19822782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.